MIND Foods and Aerobic Training in Black Adults With HTN
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-75
SponsorIndiana University
About this trial
The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure.
Researchers will compare Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) versus Enhanced Usual Care (EUC) to evaluate the effects on cognition.
Participants will complete cognitive and cardiovascular assessments, 24-hr blood pressure monitoring, standard blood pressure measurements, weight, fingerstick for HbA1c point-of-care testing, and questionnaires.
Participants may also choose to participate in an optional blood draw for DNA Repair Capacity testing as a modifiable risk factor for aging-associated diseases.
Eligibility criteria
Qualifiers
Fluent in English
Marion County resident
35-75 years
Self-identified non-Hispanic and Black/African-American/biracial including African-American
Disqualifiers
lives in nursing home
diagnosis of dementia or Alzheimer disease or mild cognitive impairment; Parkinson disease; brain tumor/infection/surgery (within the last 10 years with residual symptoms and/or functional loss/deficit, such as impaired learning, memory, or communication); cancer with short life expectancy, or current chemotherapy or radiation therapy; psychosis, schizophrenia, or bipolar disorder
ICD 10 code I11/hypertensive heart disease, ICD 10 code I12/hypertensive CKD, ICD 10 code I13/hypertensive heart disease and CKD, ICD 10 code I15, or ICD 10 code I16
current or past prescription of donepezil, memantine, rivastigmine, or galantamine
Trial design
Treatments tested in this trial
- Enhanced Usual Care (EUC)
- Food Delivery and Cooking PLUS Aerobic Training (FoRKS+)
Treatment groups
128 Participants
are divided into 2 treatment groupsSponsors and collaborators
Indiana University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute on Aging (NIA)
Collaborator
Source ClinicalTrials.gov